Liam Ratcliffe

Liam Ratcliffe is a declared insider at 7 companies (senior executive); the most frequent names are Arvinas, Inc., Array Biopharma Inc and Aptinyx Inc. In total, 77 filings cover trades dated from 4 September 2013 to 16 December 2021.

Both buying and selling appear: 12 purchases worth €58.7M, against 47 sales worth €60.2M. The net balance comes to €1.5M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 option exercises. 2021 to date brings no purchases and 39 sales.

A typical purchase (the median) is worth €3.9M. On 8 out of 10 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 6 purchases show a median change of +2.9%, with the price up in 50% of them. Past outcomes like these are no guarantee of what comes next.

Most recently, on 16 December 2021, the filings show an open-market sale worth €2.1M in Arvinas, Inc. The latest purchase dates back some time: it was published 2,148 days ago, on 21 December 2020. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.